ASCO-GU Interview | Dr. Shun Zhang: The Value and Development of Genetic Testing in Precision Treatment of Prostate Cancer
Editor's note: Precision treatment begins with testing. PARP inhibitors (PARPi) such as olaparib have become a precision treatment option for metastatic castration-resistant prostate cancer (mCRPC), offering therapeutic benefits to patients…